Inventiva (IVA) Other Non-Current Assets (2018 - 2025)

Inventiva (IVA) recorded quarterly Other Non-Current Assets of $1.4 million in Q4 2025, down 99.89% quarter-over-quarter from $1.2 billion in Q2 2025, and up 20.9% on a YoY basis from $1.1 million in Q4 2024.

Inventiva (IVA) Other Non-Current Assets (2018 - 2025) Analysis & Trends

Inventiva's Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $1.4 million for Q4 2025.

  • In Q4 2025, Other Non-Current Assets rose 20.9% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (up 20.9% YoY), while the FY2025 annual figure was $1.4 million, up 20.9% from the prior year.
  • Other Non-Current Assets was $1.4 million for Q4 2025 at Inventiva, down from $1.2 billion in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.7 billion in Q2 2022 to a low of $1.1 million in Q4 2024.
  • Historically, Other Non-Current Assets has averaged $269.2 million across 5 years, with a median of $3.3 million in 2021.
  • The sharpest annual moves came in 2023 and 2025: Other Non-Current Assets plunged 99.36% in 2023, then jumped 105014.01% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $2.8 million in 2021, then sank by 39.08% to $1.7 million in 2022, then soared by 535.72% to $10.8 million in 2023, then plunged by 89.66% to $1.1 million in 2024, then increased by 20.9% to $1.4 million in 2025.
  • The last three Other Non-Current Assets figures came in at $1.4 million (Q4 2025), $1.2 billion (Q2 2025), and $1.1 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - 289.41 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 12.40 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 60,000.00
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 1.26 Bn
9 Abivax 95.45 Bn 95.45 Bn - -
10 Inventiva 8.93 Mn -259.80 Mn - 1.35 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.35 Mn
Jun 30, 2025 1.19 Bn
Dec 31, 2024 1.12 Mn
Jun 30, 2024 1.13 Mn
Dec 31, 2023 10.82 Mn
Jun 30, 2023 11.20 Mn
Dec 31, 2022 1.70 Mn
Jun 30, 2022 1.74 Bn
Dec 31, 2021 2.79 Mn
Jun 30, 2021 4.15 Mn
Mar 31, 2021 3.32 Mn
Dec 31, 2020 2.03 Mn
Jun 30, 2020 4.56 Mn
Dec 31, 2019 3.47 Mn
Dec 31, 2018 2.71 Mn